Microbe Protein Lets Bacteria Make Drug Molecules Safely
University of Michigan researchers identify a protein that helps microbes produce drug-like molecules while shielding themselves from harmful byproducts.
Updated on Nov. 20, 2026 in Science

University of Michigan researchers discovered a protein that strengthens chemical reactions producing drug-like molecules while protecting the microbe from their harmful byproducts. The study, published in Science, emerged from work on how Streptomyces bacteria make the cancer drug doxorubicin.
Why it matters
Approximately half of all pharmaceuticals on the market originate from microbially produced natural chemicals, making the mechanisms behind their production scientifically significant. Understanding how microbes manage their own chemical reactions could help researchers develop new drug-producing methods.
The study identified a family of more than 40,000 REACT proteins across plants, bacteria, and fungi, based on bioinformatic and genetic analyses. Researchers have not stated how many of these proteins have confirmed biological functions, or how quickly they could be applied to drug production.
The players
University of Michigan
A public research university in Ann Arbor, Michigan, home to the institution whose researchers led the study.
David Sherman
A University of Michigan researcher whose lab investigated how Streptomyces bacteria produce doxorubicin.
The details
Researchers in David Sherman's lab were studying how Streptomyces bacteria produce doxorubicin when they found that the CYP450 enzyme converting the starting compound also degraded the drug. A nearby gene, DnrV, was found to protect the product and enhance CYP450 function by shielding the organism from reactive oxygen species generated during the reactions.
Timeline
November 19, 2026: Study publication date reported by phys.org.
The Big Picture
Doxorubicin is a well-established product of Streptomyces bacteria, and this discovery explains a previously unexplained protective mechanism behind its production. The findings place the REACT protein family within the broader effort to identify natural products that microbes make and protect.
The discovery could eventually lead to more efficient methods for producing natural drug compounds. Researchers suggest REACT proteins may help identify biologically important natural products not yet discovered.
The takeaway
Microbes produce many of the medicines people rely on, and tracing the proteins that protect them during production could help scientists unlock new drugs. Readers following drug development can watch for follow-up research on the REACT protein family.
Further reading
Explore more on Life Sciences research from the region.
Source note: This article includes information reported by Phys.






